4017.SR
Nahdi Medical
Health Care · Drug Retail · Tadawul
$36.16
Data: 2026-05-13
✗ ETHICAL FAIL
N/A MOAT
HIGH
Data Confidence: 85.7%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$8.2B
Total market value of the company
0.00
Rev Growth
0.0%
Year-over-year revenue change
Profit Margin
0.1%
How much profit the company keeps from each dollar of revenue
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About Nahdi Medical
Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia.
Country: Saudi Arabia Industry: Medical Care Facilities
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
20.3% PASS
Debt must be below 33% of total assets
Cash Ratio
10.0% PASS
Interest-bearing cash below 33% of assets
Receivables
16.8% PASS
Receivables below 49% of assets
Revenue Purity
-2.6% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Annual Return
-22.5%
Historical annualised return based on price data
Days in State
14
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
Short % Float
N/A
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
N/A
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
4.7%
Profit from core operations before interest and tax
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-13